Expanding role of ovarian suppression/ablation in premenopausal ER-positive breast cancer: issues and opportunities.
Schem
Christian
C
Department of Obstetrics and Gynecology, Campus Kiel, University Clinic of Schleswig-Holstein, Kiel, Germany.
Jonat
Walter
W
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D005260:Female; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D010053:Ovary / Q000187:drug effects*; D017697:Premenopause; D011960:Receptors, Estrogen / Q000032:analysis*
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; D017273:Goserelin